Jan-16
TEXT
Ataxia UK welcomes the news that Leiden-based biotech company ProQR are expanding their research interests and are now working on Friedreich’s ataxia. Dr Julie Greenfield, Ataxia UK’s Research Manager says ‘We first met with Sarah Hafith, ProQR’s business and operations manager, at the World Orphan drug conference in November 2014 and discussed the ataxias as …